---
title: "BILLEN DANIEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e6780f95-e9d4-5659-b5b4-2c8f3e203789
json: https://whiteintel.dev/api/public/dossier/e6780f95-e9d4-5659-b5b4-2c8f3e203789
identifier: sec:0001837593
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BILLEN DANIEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001837593`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e6780f95-e9d4-5659-b5b4-2c8f3e203789  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e6780f95-e9d4-5659-b5b4-2c8f3e203789  

## Ownership & control

### Holdings / subsidiaries

- **Aurinia Pharmaceuticals Inc.** (director) — https://whiteintel.dev/entity/364af349-9e6d-5c2b-89df-b04cea30ff72

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BILLEN DANIEL**. Human view: https://whiteintel.dev/entity/e6780f95-e9d4-5659-b5b4-2c8f3e203789 · Structured JSON: https://whiteintel.dev/api/public/dossier/e6780f95-e9d4-5659-b5b4-2c8f3e203789._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._